Trademark: 90906526
Word
RYDEXTO
Status
Pending
Status Code
733
Status Date
Wednesday, August 7, 2024
Serial Number
90906526
Mark Type
4
Filing Date
Friday, August 27, 2021
Published for Opposition
Tuesday, June 21, 2022

Trademark Owner History
Johnson & Johnson - Owner At Publication

Classifications
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Events
Aug 31, 2021
New Application Entered
May 12, 2022
Assigned To Examiner
Jun 1, 2022
Notification Of Notice Of Publication E-Mailed
Jun 21, 2022
Published For Opposition
Jun 21, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
New Application Office Supplied Data Entered
May 17, 2022
Approved For Pub - Principal Register
Aug 16, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 7, 2023
Sou Teas Extension Received
Feb 7, 2023
Sou Extension 1 Filed
Feb 7, 2023
Sou Extension 1 Granted
Feb 12, 2024
Sou Extension 3 Filed
Feb 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2023
Sou Teas Extension Received
Aug 10, 2023
Sou Extension 2 Filed
Aug 10, 2023
Sou Extension 2 Granted
Aug 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 12, 2024
Sou Teas Extension Received
Feb 12, 2024
Sou Extension 3 Granted
Aug 7, 2024
Sou Teas Extension Received
Aug 7, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 7, 2024
Sou Extension 4 Filed
Aug 7, 2024
Sou Extension 4 Granted
Feb 13, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24